Tozorakimab

Modify Date: 2024-09-12 18:25:25

Tozorakimab structure	Common Name	Tozorakimab
	CAS Number	2376858-66-9	Molecular Weight	15.03
	Density	N/A	Boiling Point	N/A
	Molecular Formula	CH₃	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Tozorakimab

Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab can be used to research chronic obstructive pulmonary disease[1].

Name	Tozorakimab

Description	Tozorakimab (MEDI-3506) is a human immunoglobulin G1 monoclonal antibody targeting interleukin-33. Tozorakimab can be used to research chronic obstructive pulmonary disease[1].
Related Catalog	Signaling Pathways >> Immunology/Inflammation >> Interleukin Related Research Areas >> Inflammation/Immunology
References	[1]. F. Reid, et al. Safety, Pharmacokinetics and Immunogenicity of the Anti-Interleukin-33 Antibody, Tozorakimab: Results of a Phase 1 Study in Healthy Adults and Patients with Chronic Obstructive Pulmonary Disease.

Molecular Formula	CH₃
Molecular Weight	15.03